More Than 10% of Samples From a Stool-based Colorectal Cancer Test May Be Unsatisfactory
Fewer than half of patients with unsatisfactory samples from fecal immunochemical tests completed follow-up testing within 15 months PHILADELPHIA...
Search/Filter
Loading...
AACR Applauds Confirmation of Dr. Monica Bertagnolli as NIH Director
PHILADELPHIA – Philip D. Greenberg, MD, FAACR, President of the American Association for Cancer Research (AACR), and Margaret Foti,...
Nearly Half of Oncology Drugs Approved Since 1998 Are Precision Therapies
Cancer patients eligible for precision oncology therapies nearly doubled between 2017 and 2022 PHILADELPHIA – Of the 198 new...
Investigational Inhibitor of Active RAS Shows Clinical Promise
The therapy uses a different mechanism than approved KRAS G12C inhibitors and targets multiple RAS mutations beyond KRAS G12C...
New Investigational Targeted Therapy Shows Early Promise in Patients With Solid Tumors
Second-generation PRMT5 inhibitor targets synthetic lethality in several cancer types with MTAP loss BOSTON – AMG 193, a second-generation...
AACR Congratulates Fellows, Board Members, and Members Elected to the National Academy of Medicine
PHILADELPHIA – The American Association for Cancer Research (AACR) extends its warmest congratulations to the 15 AACR members who...
AACR Statement on Senator Dianne Feinstein’s Passing
Today, the American Association for Cancer Research (AACR) issued the following statement regarding the death of Senator Dianne Feinstein:...
Folakemi T. Odedina, PhD, Recognized with 2023 AACR Distinguished Lectureship on the Science of Cancer Health Disparities
ORLANDO, Fla. – The American Association for Cancer Research (AACR) will award Folakemi T. Odedina, PhD, with the 2023...
Structural Racism May Play a Role in Increased Cancer Mortality Rates Among Racial Minorities
ORLANDO, Fla. – Structural racism was associated with increased county-level cancer mortality rates among minority populations compared with whites,...
Racial and Ethnic Minorities May Be Less Willing Than Others to Participate in Clinical Trials
Survey found that most people are open to participating, and motivation varied by racial and ethnic group ORLANDO, Fla....